355
Views
76
CrossRef citations to date
0
Altmetric
Original

Current CHS and NHBPEP Criteria for Severe Preeclampsia Do Not Uniformly Predict Adverse Maternal or Perinatal Outcomes

, , , , , , , , , , , , , , & show all
Pages 447-462 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Lyndsay Creswell, Neil O’Gorman, Kirsten Rebecca Palmer, Fabricio da Silva Costa & Daniel Lorber Rolnik. (2023) Perspectives on the Use of Placental Growth Factor (PlGF) in the Prediction and Diagnosis of Pre-Eclampsia: Recent Insights and Future Steps. International Journal of Women's Health 15, pages 255-271.
Read now
Ahmed M. Abbas, Engy M. Fikry, Taha S. Mostafa, Asmaa S. Shaltout & Mona A.H. El-Baz. (2018) Prognostic value of serum soluble FMS-like tyrosine kinase (sFlt-1) levels in pre-eclampsia and eclampsia; a prospective cohort study. Hypertension in Pregnancy 37:3, pages 137-143.
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Steven J. Korzeniewski, Josef M. Cortez, Athina Pappas, Adi L. Tarca, Piya Chaemsaithong, Zhong Dong, Lami Yeo & Sonia S. Hassan. (2014) Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. The Journal of Maternal-Fetal & Neonatal Medicine 27:2, pages 132-144.
Read now
Louise M Webster & Andrew H Shennan. (2013) The potential of placental growth factor in the diagnosis and management of pre-eclampsia. Expert Review of Obstetrics & Gynecology 8:4, pages 305-307.
Read now
Sarosh Rana, William T. Schnettler, Camille Powe, Julia Wenger, Saira Salahuddin, Ana Sofia Cerdeira, Stefan Verlohren, Frank H. Perschel, Zoltan Arany, Kee-Hak Lim, Ravi Thadhani & S. Ananth Karumanchi. (2013) Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertension in Pregnancy 32:2, pages 189-201.
Read now
Andreea G. Moore, Heather Young, Jennifer M. Keller, Linda R. Ojo, Jing Yan, Tiffany A. Moore Simas & Sharon E. Maynard. (2012) Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 25:12, pages 2651-2657.
Read now
Whitney B. You, Michael Wolf, Stacy Cooper Bailey, Anjali U. Pandit, Katherine R. Waite, Rina M. Sobel & William Grobman. (2012) Factors Associated with Patient Understanding of Preeclampsia. Hypertension in Pregnancy 31:3, pages 341-349.
Read now
Corine M. Koopmans, Joost J. Zwart, Henk Groen, Kitty W.M. Bloemenkamp, Ben W.J. Mol, Maria G. Van Pampus & Jos Van Roosmalen. (2011) Risk Indicators for Eclampsia in Gestational Hypertension or Mild Preeclampsia at Term. Hypertension in Pregnancy 30:4, pages 433-446.
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Zeynep Alpay Savasan, Juan Pedro Kusanovic, Giovanna Ogge, Eleazar Soto, Zhong Dong, Adi Tarca, Bhatti Gaurav & Sonia S. Hassan. (2011) Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 24:10, pages 1187-1207.
Read now
Barry N. J. Walters. (2011) Preeclamptic Angina – A Pathognomonic Symptom of Preeclampsia. Hypertension in Pregnancy 30:2, pages 117-124.
Read now

Articles from other publishers (66)

Katherine G.Y. Lau, Emmanouil Kountouris, Laura Salazar-Rios, Kypros H. Nicolaides & Nikos A. Kametas. (2023) Prediction of adverse outcome by ophthalmic artery Doppler and angiogenic markers in pregnancies with new onset hypertension. Pregnancy Hypertension 34, pages 110-115.
Crossref
Eugenio D. Martinez Hurtado & Míriam Sánchez Merchante. 2022. Obstetric Anesthesia: Clinical Updates. Obstetric Anesthesia: Clinical Updates 204 257 .
Junjun Chen, Yuelong Ji, Tao Su, Ma Jin, Zhichao Yuan, Yuanzhou Peng, Shuang Zhou, Heling Bao, Shusheng Luo, Hui Wang, Jue Liu, Na Han & Hai-Jun Wang. (2022) Prediction of Adverse Outcomes in De Novo Hypertensive Disorders of Pregnancy: Development and Validation of Maternal and Neonatal Prognostic Models. Healthcare 10:11, pages 2307.
Crossref
Deesha Patel & Angela Yulia. (2022) Placental growth factor testing for pre-eclampsia. Case Reports in Women's Health 33, pages e00387.
Crossref
Kirim Hong, Hee J Park & Dong H Cha. (2021) Clinical implications of placenta-derived angiogenic/anti-angiogenic biomarkers in pre-eclampsia. Biomarkers in Medicine 15:7, pages 523-536.
Crossref
Kate E. Duhig, Jenny E. Myers, Chris Gale, Joanna C. Girling, Kate Harding, Andrew Sharp, Nigel A.B. simpson, Derek Tuffnell, Paul T. Seed, Andrew H. Shennan & Lucy C. Chappell. (2021) Placental growth factor measurements in the assessment of women with suspected Preeclampsia: A stratified analysis of the PARROT trial. Pregnancy Hypertension 23, pages 41-47.
Crossref
Jason Raina, Amira El-Messidi, Ahmad Badeghiesh, Togas Tulandi, Tuong-Vi Nguyen & Eva Suarthana. (2021) Pregnancy hypertension and its association with maternal anxiety and mood disorders: A population-based study of 9 million pregnancies. Journal of Affective Disorders 281, pages 533-538.
Crossref
Elisa Simón, Celia Permuy, Laura Sacristán, María José Zamoro-Lorenci, Cecilia Villalaín, Alberto Galindo & Ignacio Herraiz. (2020) sFlt-1/PlGF ratio for the prediction of delivery within 48 hours and adverse outcomes in expectantly managed early-onset preeclampsia. Pregnancy Hypertension 22, pages 17-23.
Crossref
Jing Tan, Min Yang, Yuan Liao, Yana Qi, Yan Ren, Chunrong Liu, Shiyao Huang, Lehana Thabane, Xinghui Liu & Xin Sun. (2020) Development and validation of a prediction model on severe maternal outcomes among pregnant women with pre-eclampsia: a 10-year cohort study. Scientific Reports 10:1.
Crossref
Alfredo Leaños-MirandaAna Graciela Nolasco-LeañosReyes Ismael Carrillo-JuárezCarlos José Molina-PérezLiliana Janet Sillas-PardoLuis Manuel Jiménez-TrejoIrma Isordia-SalasKarla Leticia Ramírez-Valenzuela. (2020) Usefulness of the sFlt-1/PlGF (Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor) Ratio in Diagnosis or Misdiagnosis in Women With Clinical Diagnosis of Preeclampsia. Hypertension 76:3, pages 892-900.
Crossref
Cecilia Villalain, Ignacio Herraiz, Borja Cantero, Soledad Quezada, Ana Lopez, Elisa Simón & Alberto Galindo. (2020) Angiogenesis biomarkers for the prediction of severe adverse outcomes in late-preterm preeclampsia. Pregnancy Hypertension 19, pages 74-80.
Crossref
Sukumar Mitra & Seema Das. (2019) Postpartum Eclampsia- A Prospective Observational Hospital Based Study. Journal of Evolution of Medical and Dental Sciences 8:52, pages 3984-3988.
Crossref
Rachael Fox, Jamie Kitt, Paul Leeson, Christina Y.L. Aye & Adam J. Lewandowski. (2019) Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring. Journal of Clinical Medicine 8:10, pages 1625.
Crossref
Alfredo Leaños-Miranda, Claudia Stephanny Navarro-Romero, Liliana Janet Sillas-Pardo, Karla Leticia Ramírez-Valenzuela, Irma Isordia-SalasLuis Manuel Jiménez-Trejo. (2019) Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes. Hypertension 74:4, pages 991-997.
Crossref
Gordon Haire, Karl Egan, Kiran Parmar, Tom McKinnon, Cathy Monteith, Hugh O’Connor, Barry Kevane, Patricia Maguire, Paulina B. Szklanna, Marie Galligan, Jennifer C Donnelly, Seamus Allen, Naomi McCallion, Beverley Hunt & Fionnuala Ní Áinle. (2019) Alterations in fibrin formation and fibrinolysis in early onset-preeclampsia: Association with disease severity. European Journal of Obstetrics & Gynecology and Reproductive Biology 241, pages 19-23.
Crossref
Kate E Duhig, Jenny Myers, Paul T Seed, Jenie Sparkes, Jessica Lowe, Rachael M Hunter, Andrew H Shennan, Lucy C Chappell, Rachna Bahl, Gabrielle Bambridge, Sonia Barnfield, Jo Ficquet, Carolyn Gill, Joanna Girling, Kate Harding, Asma Khalil, Andrew Sharp, Nigel Simpson & Derek Tuffnell. (2019) Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. The Lancet 393:10183, pages 1807-1818.
Crossref
Yuhong Sun, Yan Hou, Nan Lv, Qian Liu, Nan Lin, Shuyu Zhao, Xiaodan Chu, Xuan Chen, Guobin Cheng & Peiling Li. (2019) Circulating lncRNA BC030099 Increases in Preeclampsia Patients. Molecular Therapy - Nucleic Acids 14, pages 562-566.
Crossref
Ignacio Herraiz García, Elisa Llurba Olive, Alberto Galindo Izquierdo & Stefan Verlohren. (2019) Actualización del diagnóstico y el pronóstico de la preeclampsia en embarazos únicos con la ayuda del cociente sFlt-1/PlGF. Progresos de Obstetricia y Ginecología.
Crossref
Stephanie E. Reilly, Shaun P. Brennecke, Jacqui Smith, Michael J. Stewart & Rosemarie A. Boland. (2018) Clinical features and outcomes of pregnancies complicated by pre-ecplampsia necessitating in-utero transfer. Pregnancy Hypertension 14, pages 162-167.
Crossref
U. Vivian Ukah, Dane A. De Silva, Beth Payne, Laura A. Magee, Jennifer A. Hutcheon, Helen Brown, J. Mark Ansermino, Tang Lee & Peter von Dadelszen. (2018) Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review. Pregnancy Hypertension 11, pages 115-123.
Crossref
Jason Waugh, Richard Hooper, Edmund Lamb, Stephen Robson, Andrew Shennan, Fiona Milne, Christopher Price, Shakila Thangaratinam, Vladislav Berdunov & Jenn Bingham. (2017) Spot protein–creatinine ratio and spot albumin–creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis. Health Technology Assessment 21:61, pages 1-90.
Crossref
M. Sarmiento-Piña, E. Reyna-Villasmil, J. Mejia-Montilla, J. Santos-Bolívar, D. Torres-Cepeda & N. Reyna-Villasmil. (2017) Valor predictivo de la proteinuria en 24 horas en la resultante neonatal de las preeclámpsicas. Clínica e Investigación en Ginecología y Obstetricia 44:3, pages 119-124.
Crossref
Mi Jung KimYoung Nam Kim, Eun Jung JungHye Ree JangJung Mi ByunDae Hoon JeongMoon Su SungKyung Bok LeeKi Tae Kim. (2017) Is massive proteinuria associated with maternal and fetal morbidities in preeclampsia?. Obstetrics & Gynecology Science 60:3, pages 260.
Crossref
Eva F. Zwertbroek, Kim Broekhuijsen, Josje Langenveld, Gert-Jan van Baaren, Paul P. van den Berg, Henk A. Bremer, Wessel Ganzevoort, Aren J. van Loon, Ben W.J. Mol, Maria G. van Pampus, Denise A.M. Perquin, Robbert J.P. Rijnders, Hubertina C.J. Scheepers, Marko J. Sikkema, Mallory D. Woiski, Henk Groen & Maureen T.M. Franssen. (2017) Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy. Acta Obstetricia et Gynecologica Scandinavica 96:1, pages 96-105.
Crossref
Pooja Mathur, Poonam Mathur, Laxmi Maru & Anupama Dave. (2015) A Prospective Study of Placental Growth Factor Assay as a Novel Biomarker in Predicting Early-Onset Preeclampsia in High-Risk Patients. The Journal of Obstetrics and Gynecology of India 66:S1, pages 98-103.
Crossref
Shruti Agrawal & Nandita Maitra. (2015) Prediction of Adverse Maternal Outcomes in Preeclampsia Using a Risk Prediction Model. The Journal of Obstetrics and Gynecology of India 66:S1, pages 104-111.
Crossref
Suzy Duckworth, Melanie Griffin, Paul T. Seed, Robyn North, Jenny Myers, Lucy Mackillop, Nigel Simpson, Jason Waugh, Dilly Anumba, Louise C. Kenny, Christopher W. G. Redman, Andrew H. Shennan & Lucy C. Chappell. (2016) Diagnostic Biomarkers in Women With Suspected Preeclampsia in a Prospective Multicenter Study. Obstetrics & Gynecology 128:2, pages 245-252.
Crossref
Kate S Wiles & Anita Banerjee. (2016) Acute kidney injury in pregnancy and the use of non-steroidal anti-inflammatory drugs. The Obstetrician & Gynaecologist 18:2, pages 127-135.
Crossref
Nathalie Acestor, Jane Goett, Arthur Lee, Tara M. Herrick, Susheela M. Engelbrecht, Claudia M. Harner-Jay, Bonnie J. Howell & Bernhard H. Weigl. (2016) Towards biomarker-based tests that can facilitate decisions about prevention and management of preeclampsia in low-resource settings. Clinical Chemistry and Laboratory Medicine (CCLM) 54:1.
Crossref
Sandra A. Lowe, Lucy Bowyer, Karin Lust, Lawrence P. McMahon, Mark Morton, Robyn A. North, Michael Paech & Joanne M. Said. (2015) SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Australian and New Zealand Journal of Obstetrics and Gynaecology 55:5, pages e1-e29.
Crossref
Ignacio Herraiz, Elisa Simón, Paula Gómez-Arriaga, José Martínez-Moratalla, Antonio García-Burguillo, Elena Jiménez & Alberto Galindo. (2015) Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration. International Journal of Molecular Sciences 16:8, pages 19009-19026.
Crossref
C.M. Ortner, B. Combrinck, S. Allie, D. Story, R. Landau, K. Cain & R.A. Dyer. (2015) Strong ion and weak acid analysis in severe preeclampsia: potential clinical significance. British Journal of Anaesthesia 115:2, pages 275-284.
Crossref
Glenn E. Palomaki, James E. Haddow, Hamish R. M. Haddow, Saira Salahuddin, Carl Geahchan, Ana Sofia Cerdeira, Stefan Verlohren, Frank H. Perschel, Gary Horowitz, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2015) Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia. Prenatal Diagnosis 35:4, pages 386-393.
Crossref
Peter von Dadelszen & Laura A. Magee. (2014) Pre-eclampsia: An Update. Current Hypertension Reports 16:8.
Crossref
P. I. Gómez-Arriaga, I. Herraiz, E. A. López-Jiménez, D. Escribano, B. Denk & A. Galindo. (2014) Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia. Ultrasound in Obstetrics & Gynecology 43:5, pages 525-532.
Crossref
Sarosh RanaS. Ananth KarumanchiMarshall D. Lindheimer. (2014) Angiogenic Factors in Diagnosis, Management, and Research in Preeclampsia. Hypertension 63:2, pages 198-202.
Crossref
Nazli Hossain, Nazeer Khan, Nusrat Shah, Tahira Shah, Sofia Butt & Rafiq Khanani. (2014) Spot urine protein–creatinine ratio and 24-h urine protein excretion: Diagnostic accuracy in women with pre-eclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 4:1, pages 87-90.
Crossref
Edailna Maria de Melo Dantas, Flávio Venicio Marinho Pereira, José Wilton Queiroz, Diogo Luis de Melo Dantas, Gloria Regina Gois Monteiro, Priya Duggal, Maria de Fatima Azevedo, Selma Maria Bezerra Jeronimo & Ana Cristina Pinheiro Fernandes Araújo. (2013) Preeclampsia is associated with increased maternal body weight in a northeastern Brazilian population. BMC Pregnancy and Childbirth 13:1.
Crossref
Lucy C. ChappellSuzy DuckworthPaul T. SeedMelanie GriffinJenny MyersLucy MackillopNigel SimpsonJason WaughDilly AnumbaLouise C. KennyChristopher W.G. RedmanAndrew H. Shennan. (2013) Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia. Circulation 128:19, pages 2121-2131.
Crossref
Arvind Goel & Sarosh Rana. (2013) Angiogenic factors in preeclampsia. Current Opinion in Nephrology & Hypertension 22:6, pages 643-650.
Crossref
Alfredo Leaños-MirandaInova Campos-GaliciaKarla Leticia Ramírez-ValenzuelaZarela Lizbeth Chinolla-ArellanoIrma Isordia-Salas. (2013) Circulating Angiogenic Factors and Urinary Prolactin as Predictors of Adverse Outcomes in Women With Preeclampsia. Hypertension 61:5, pages 1118-1125.
Crossref
Sarosh Rana, Ana Sofia Cerdeira, Julia Wenger, Saira Salahuddin, Kee-Hak Lim, Steven J. Ralston, Ravi I. Thadhani & S. Ananth Karumanchi. (2012) Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia. PLoS ONE 7:10, pages e48259.
Crossref
Peter von Dadelszen, Tabassum Firoz, France Donnay, Rebecca Gordon, G. Justus Hofmeyr, Shifana Lalani, Beth A. Payne, James M. Roberts, Katherine C. Teela, Marianne Vidler, Diane Sawchuck & Laura A. Magee. (2012) Preeclampsia in Low and Middle Income Countries—Health Services Lessons Learned From the PRE-EMPT (PRE-Eclampsia–Eclampsia Monitoring, Prevention & Treatment) Project. Journal of Obstetrics and Gynaecology Canada 34:10, pages 917-926.
Crossref
Sarosh RanaCamille E. PoweSaira SalahuddinStefan VerlohrenFrank H. PerschelRichard J. LevineKee-Hak LimJulia B. WengerRavi ThadhaniS. Ananth Karumanchi. (2012) Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia. Circulation 125:7, pages 911-919.
Crossref
John France & Projestine S. Muganyizi. (2012) Characteristics of symptoms of imminent eclampsia: A case referent study from a tertiary hospital in Tanzania. Open Journal of Obstetrics and Gynecology 02:03, pages 311-317.
Crossref
Etienne Ciantar & James J Walker. (2011) Pre-Eclampsia, Severe Pre-Eclampsia and Hemolysis, Elevated Liver Enzymes and Low Platelets Syndrome: What is New?. Women's Health 7:5, pages 555-569.
Crossref
Janie Benoit & Évelyne Rey. (2011) Preeclampsia: Should Plasma Albumin Level Be a Criterion for Severity?. Journal of Obstetrics and Gynaecology Canada 33:9, pages 922-926.
Crossref
Beth Payne, Laura A. Magee & Peter von Dadelszen. (2011) Assessment, surveillance and prognosis in pre-eclampsia. Best Practice & Research Clinical Obstetrics & Gynaecology 25:4, pages 449-462.
Crossref
Jennifer A. Hutcheon, Sarka Lisonkova & K.S. Joseph. (2011) Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology 25:4, pages 391-403.
Crossref
Tin-Wing Yen, Beth Payne, Ziguang Qu, Jennifer A. Hutcheon, Tang Lee, Laura A Magee, Barry N. Walters & Peter von Dadelszen. (2011) Using Clinical Symptoms to Predict Adverse Maternal and Perinatal Outcomes in Women With Preeclampsia: Data From the PIERS (Pre-eclampsia Integrated Estimate of RiSk) Study. Journal of Obstetrics and Gynaecology Canada 33:8, pages 803-809.
Crossref
Alexandra L. Millman, Beth Payne, Ziguang Qu, M. Joanne Douglas, Jennifer A. Hutcheon, Tang Lee, Laura A. Magee, Keith R. Walley & Peter von Dadelszen. (2011) Oxygen Saturation as a Predictor of Adverse Maternal Outcomes in Women with Preeclampsia. Journal of Obstetrics and Gynaecology Canada 33:7, pages 705-714.
Crossref
SHAKILA THANGARATINAM, CORINE M. KOOPMANS, SHALINI IYENGAR, JAVIER ZAMORA, KHALED M.K. ISMAIL, BEN W.J. MOL & KHALID S. KHAN. (2011) Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review. Acta Obstetricia et Gynecologica Scandinavica 90:6, pages 574-585.
Crossref
SHAKILA THANGARATINAM, IOANNIS D. GALLOS, NEKI MEAH, SA’ADA USMAN, KHALED M.K. ISMAIL & KHALID S. KHAN. (2011) How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis. Acta Obstetricia et Gynecologica Scandinavica 90:6, pages 564-573.
Crossref
Beth Payne, Laura A. Magee, Anne-Marie Côté, Jennifer A. Hutcheon, Jing Li, Phillipa M. Kyle, Jennifer M. Menzies, M. Peter Moore, Claire Parker, Barbra Pullar, Peter von Dadelszen, Barry N. Walters, P. von Dadelszen, L.A. Magee, M.J. Douglas, K.R. Walley, J.A. Russell, S.K. Lee, A. Gruslin, G.N. Smith, A.M. Côté, J.-M. Moutquin, M.A. Brown, G. Davis, B.N. Walters, N. Sass, T. Duan, J. Zhou, S. Mahajan, A. Noovao, L.A. McCowan, P. Kyle, M.P. Moore, S.Z. Bhutta, Z.A. Bhutta, Hall, D.W. Steyn, F. Broughton Pipkin, P. Loughna, S. Robson, M. de Swiet, J.J. Walker, W.A. Grobman, M.D. Lindheimer, J.M. Roberts, J. Mark Ansermino, Samantha Benton, Geoff Cundiff, Dany Hugo, K.S. Joseph, Sayrin Lalji, Jing Li, Paula Lott, Annie B. Ouellet, Dorothy Shaw, D. Keith Still, George Tawagi, Brenda Wagner, Christine Biryabarema, Florence Mirembe, Annettee Nakimuli, Eleni Tsigas, Mario Merialdi & Mariana Widmer. (2011) PIERS Proteinuria: Relationship With Adverse Maternal and Perinatal Outcome. Journal of Obstetrics and Gynaecology Canada 33:6, pages 588-597.
Crossref
Peter von Dadelszen, Beth A Payne, Jennifer A Hutcheon, KS Joseph & Laura A Magee. (2011) Prediction of pre-eclampsia complications – Authors' reply. The Lancet 377:9774, pages 1314.
Crossref
Peter von Dadelszen, Beth Payne, Jing Li, J Mark Ansermino, Fiona Broughton Pipkin, Anne-Marie Côté, M Joanne Douglas, Andrée Gruslin, Jennifer A Hutcheon, KS Joseph, Phillipa M Kyle, Tang Lee, Pamela Loughna, Jennifer M Menzies, Mario Merialdi, Alexandra L Millman, M Peter Moore, Jean-Marie Moutquin, Annie B Ouellet, Graeme N Smith, James J Walker, Keith R Walley, Barry N Walters, Mariana Widmer, Shoo K Lee, James A Russell & Laura A Magee. (2011) Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. The Lancet 377:9761, pages 219-227.
Crossref
Francesc Figueras. (2010) Reply. American Journal of Obstetrics and Gynecology 203:6, pages e12-e13.
Crossref
Marshall D. Lindheimer, Sandra J. Taler & F. Gary Cunningham. (2010) Hypertension in pregnancy. Journal of the American Society of Hypertension 4:2, pages 68-78.
Crossref
G Justus Hofmeyr & Michael Belfort. (2009) Proteinuria as a predictor of complications of pre-eclampsia. BMC Medicine 7:1.
Crossref
SD McDonald, C Best & K Lam. (2009) The recurrence risk of severe de novo pre-eclampsia in singleton pregnancies: a population-based cohort. BJOG: An International Journal of Obstetrics & Gynaecology 116:12, pages 1578-1584.
Crossref
Peter von Dadelszen, Jennifer M. Menzies, Beth Payne & Laura A. Magee. (2009) Predicting Adverse Outcomes in Women with Severe Pre-eclampsia. Seminars in Perinatology 33:3, pages 152-157.
Crossref
Young Nam Kim, Dae Shim Lee, Dae Hoon Jeong, Moon Su Sung & Ki Tae Kim. (2009) The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia. Prenatal Diagnosis 29:5, pages 464-470.
Crossref
Marshall D. Lindheimer, Sandra J. Taler & F. Gary Cunningham. (2009) ASH Position Paper: Hypertension in Pregnancy. The Journal of Clinical Hypertension 11:4, pages 214-225.
Crossref
Marshall D. Lindheimer, Sandra J. Taler & F. Gary Cunningham. (2008) Hypertension in pregnancy. Journal of the American Society of Hypertension 2:6, pages 484-494.
Crossref
Peter von Dadelszen & Laura Magee. (2008) What matters in preeclampsia are the associated adverse outcomes: the view from Canada. Current Opinion in Obstetrics & Gynecology 20:2, pages 110-115.
Crossref
S. Ananth Karumanchi & Marshall D. Lindheimer. (2007) Preeclampsia and the kidney: footprints in the urine. American Journal of Obstetrics and Gynecology 196:4, pages 287-288.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.